Dossier
weight loss drug deal
Coverage of weight loss drug deal in the Nexus archive.
- CVS Health's profit nearly tripled as it launched an Eli Lilly weight loss drug deal
CVS Health's profit nearly tripled in the second quarter, beating Wall Street expectations. The company raised its full-year profit forecast to as much as $8.10 per share due to a weight loss drug deal with Eli Lilly.